IN2014DN09216A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09216A
IN2014DN09216A IN9216DEN2014A IN2014DN09216A IN 2014DN09216 A IN2014DN09216 A IN 2014DN09216A IN 9216DEN2014 A IN9216DEN2014 A IN 9216DEN2014A IN 2014DN09216 A IN2014DN09216 A IN 2014DN09216A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jean-Marie Saint-Remy
Original Assignee
Imnate Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imnate Sarl filed Critical Imnate Sarl
Publication of IN2014DN09216A publication Critical patent/IN2014DN09216A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/20Ingredients acting on or related to the structure
    • A23V2200/218Coagulant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood
    • A61M2202/0445Proteins
    • A61M2202/0447Glycoproteins
    • A61M2202/0452Factor VIII

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN9216DEN2014 2012-05-22 2014-11-03 IN2014DN09216A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12168800.6A EP2666782A1 (en) 2012-05-22 2012-05-22 Coagulation factor VIII with reduced immunogenicity.
PCT/EP2013/060397 WO2013174805A1 (en) 2012-05-22 2013-05-21 Coagulation factor viii with reduced immunogenicity

Publications (1)

Publication Number Publication Date
IN2014DN09216A true IN2014DN09216A (pt) 2015-07-10

Family

ID=48485166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9216DEN2014 IN2014DN09216A (pt) 2012-05-22 2014-11-03

Country Status (12)

Country Link
US (1) US10087233B2 (pt)
EP (2) EP2666782A1 (pt)
JP (1) JP6363996B2 (pt)
AU (1) AU2013265400B2 (pt)
BR (1) BR112014028575B1 (pt)
CA (1) CA2872938C (pt)
DK (1) DK2852609T3 (pt)
ES (1) ES2751361T3 (pt)
HK (1) HK1203981A1 (pt)
IN (1) IN2014DN09216A (pt)
RU (1) RU2631801C2 (pt)
WO (1) WO2013174805A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3388447A1 (en) * 2017-04-14 2018-10-17 Imnate Sarl Methods to produce peptides, polypeptides or cells for modulating immunity
EP3936867A1 (en) 2020-07-06 2022-01-12 Imnate Sarl Cd1 peptide-epitope for use in the treatment of a disease caused by an intracellular pathogen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084251B1 (en) * 1987-02-12 2006-08-01 Genentech, Inc. Methods and Deoxyribonucleic acid for the preparation of tissue factor protein
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
EP0716703A1 (en) * 1993-09-03 1996-06-19 PRENDERGAST, Kenneth, Francis Glycophorin binding protein (gbp130) fusion compositions
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
WO2003087161A1 (en) * 2002-04-18 2003-10-23 Merck Patent Gmbh Modified factor viii
HUE033776T2 (en) 2004-11-12 2018-01-29 Bayer Healthcare Llc FVIII site-specific modification
WO2006103298A2 (en) * 2005-04-01 2006-10-05 Novo Nordisk Health Care Ag Blood coagulation fviii analogues
US20090110861A1 (en) 2007-10-29 2009-04-30 3M Innovative Properties Company Pressure sensitive adhesive article
US8183345B2 (en) * 2007-11-01 2012-05-22 University Of Rochester Recombinant factor VIII having reduced inactivation by activated protein C
PL2249864T3 (pl) 2008-02-14 2016-11-30 Strategie zapobiegania i/lub leczenia odpowiedzi immunologicznych na rozpuszczalne alloczynniki
EP2149603A1 (en) * 2008-07-28 2010-02-03 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Factor IX variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders
US8691211B2 (en) * 2009-03-10 2014-04-08 Puget Sound Blood Center Suppression of immune response to factor VIII in hemophilia A patients
CA2780763A1 (en) * 2009-11-13 2011-05-19 Puget Sound Blood Center Factor viii b cell epitope variants having reduced immunogenicity
AU2011333756B2 (en) * 2010-11-25 2017-06-15 Equaly S.A. Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells

Also Published As

Publication number Publication date
EP2852609B1 (en) 2019-10-09
BR112014028575B1 (pt) 2022-08-30
RU2631801C2 (ru) 2017-09-26
US20150087593A1 (en) 2015-03-26
CA2872938C (en) 2020-06-16
ES2751361T3 (es) 2020-03-31
BR112014028575A2 (pt) 2017-08-01
WO2013174805A1 (en) 2013-11-28
US10087233B2 (en) 2018-10-02
DK2852609T3 (da) 2019-11-25
EP2852609A1 (en) 2015-04-01
AU2013265400A1 (en) 2014-11-13
EP2666782A1 (en) 2013-11-27
AU2013265400B2 (en) 2017-07-27
HK1203981A1 (en) 2015-11-06
JP6363996B2 (ja) 2018-07-25
JP2015518844A (ja) 2015-07-06
CA2872938A1 (en) 2013-11-28
RU2014151719A (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
BR112014017635A2 (pt)
BR112014017614A2 (pt)
BR112014019260A2 (pt)
BR112014017625A2 (pt)
BR112014017592A2 (pt)
BR112014017659A2 (pt)
BR112014019065A2 (pt)
BR112014017646A2 (pt)
BR112014017638A2 (pt)
BR112014017607A2 (pt)
BR112013027865A2 (pt)
BR112014017634A2 (pt)
BR112014017609A2 (pt)
BR112014017644A2 (pt)
BR112014017588A2 (pt)
BR112014017647A2 (pt)
BR112014017618A2 (pt)
BR112014013184A8 (pt)
BR112014017630A2 (pt)
BR112014017652A2 (pt)
BR112014017621A2 (pt)
BR112014017622A2 (pt)
BR112014017627A2 (pt)
BR112014017623A2 (pt)
BR112014017631A2 (pt)